Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Temoporfin

Copy Product Info
😃Good
Catalog No. T17035Cas No. 122341-38-2

Temoporfin used in photodynamic therapy for the treatment of squamous cell carcinoma of the head and neck.

Temoporfin

Temoporfin

Copy Product Info
😃Good
Purity: 99.71%
Catalog No. T17035Cas No. 122341-38-2
Temoporfin used in photodynamic therapy for the treatment of squamous cell carcinoma of the head and neck.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$45In StockIn Stock
2 mg$64In StockIn Stock
5 mg$107In StockIn Stock
10 mg$187In StockIn Stock
25 mg$383In StockIn Stock
50 mg$569In StockIn Stock
100 mg$817InquiryInquiry
1 mL x 10 mM (in DMSO)$162In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.71%
Appearance:Solid
Color:Black
Contact us for more batch information

Resource Download

Product Introduction

Temoporfin AI Summary
Temoporfin demonstrates various bioactivities and physicochemical properties. It has a drug level ratio of 3.0 in tumor to skin in iv dosed BDXI rats implanted with rat LSBD1 cells after 24 hours. The compound is soluble in 25% aqueous ethanolic medium at 25°C with a solubility of 600000.0 nM. It exhibits significant antiviral activity against SARS-CoV-2, inhibiting cytotoxicity in Caco-2 cells by 85.92% at 10 µM, and has a 30.74% inhibition of SARS-CoV-2 3CL-Pro protease at 20 µM. In VERO-6 cells, it shows a 2.08% inhibition rate at 10 µM after 48 hours against SARS-CoV-2. Additionally, Temoporfin has photodynamic antibacterial activity against Enterococcus faecalis at 10 µM and 30 µM concentrations under light irradiation, with log(activity) values of 5.8 and 6.7, respectively. It displays both photodynamic cytotoxicity and dark toxicity against human A549 cells and Enterococcus faecalis. In human QBC939 cells, it shows dark toxicity with a TC50 of 6.08 µM and phototoxic effects upon 650 nm laser irradiation in QBC939 cell xenografts in mice, reducing tumor weight by 35%. The compound also demonstrates phototoxic effects against human HT-29 cells, human MDA-MB-231, mouse 4T1, and HUVEC cells, with varying IC50 values. It is a potent HDAC6 inhibitor, with inhibition percentages of 36.91% and 2.63% using different substrates. Moreover, it shows antiviral activity against West Nile virus, Zika virus, and DENV2, with EC50 values of 10.0 nM, 22.0 nM, and 20.0 nM, respectively. Additionally, it exhibits cytotoxicity against human A549 cells with a CC50 of 40700.0 nM..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Temoporfin used in photodynamic therapy for the treatment of squamous cell carcinoma of the head and neck.
Chemical Properties
Molecular Weight680.75
FormulaC44H32N4O4
Cas No.122341-38-2
SmilesOc1cccc(c1)-c1c2CCc(n2)c(-c2cccc(O)c2)c2ccc([nH]2)c(-c2cccc(O)c2)c2ccc(n2)c(-c2cccc(O)c2)c2ccc1[nH]2
Relative Density.1.386 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 27 mg/mL (39.66 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (1.47 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.4690 mL7.3448 mL14.6897 mL73.4484 mL
5 mM0.2938 mL1.4690 mL2.9379 mL14.6897 mL
10 mM0.1469 mL0.7345 mL1.4690 mL7.3448 mL
20 mM0.0734 mL0.3672 mL0.7345 mL3.6724 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Temoporfin | purchase Temoporfin | Temoporfin cost | order Temoporfin | Temoporfin chemical structure | Temoporfin formula | Temoporfin molecular weight